Cardiac Syndrome X: update 2014
Shilpa Agrawal1, Puja K Mehta2, C Noel Bairey Merz2
1David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Insights
Cardiac Syndrome X (CSX) affects many women, causing chest discomfort and poor quality of life. While treatments exist, clear therapeutic guidelines are needed for this serious heart condition.
Area of Science:
- Cardiology
- Women's Health
Background:
- Cardiac Syndrome X (CSX) presents as angina-like chest discomfort with exercise-induced ST depression, despite normal coronary arteries.
- CSX is common in women and associated with adverse cardiovascular outcomes and reduced quality of life.
- Pathogenesis involves coronary microvascular/endothelial dysfunction and abnormal cardiac nociception.
Purpose of the Study:
- To review the current understanding of Cardiac Syndrome X (CSX) in women.
- To summarize existing treatment strategies for CSX.
- To highlight the lack of comprehensive therapeutic guidelines.
Main Methods:
- Literature review of studies on Cardiac Syndrome X (CSX).
- Analysis of treatment efficacy for individual interventions.
- Identification of gaps in current clinical guidelines.
Main Results:
- Various treatments, including lifestyle changes, medications, and non-pharmacological options, have demonstrated efficacy.
- Individual treatment effectiveness is documented, but a consolidated therapeutic approach is missing.
- CSX management requires a multi-faceted strategy.
Conclusions:
- Cardiac Syndrome X (CSX) is a significant condition in women requiring effective management.
- Current treatment options offer potential benefits but lack standardized guidelines.
- Further research is needed to establish optimal therapeutic pathways for CSX.
Abstract:
Cardiac Syndrome X (CSX), characterized by angina-like chest discomfort, ST segment depression during exercise, and normal epicardial coronary arteries at angiography, is highly prevalent in women. CSX is not benign, and linked to adverse cardiovascular outcomes and a poor quality of life. Coronary microvascular and endothelial dysfunction and abnormal cardiac nociception have been implicated in the pathogenesis of CSX. Treatment includes life-style modification, anti-anginal, anti-atherosclerotic, and anti-ischemic medications. Non-pharmacological options include cognitive behavioral therapy, enhanced external counterpulsation, neurostimulation, and stellate ganglionectomy. Studies have shown the efficacy of individual treatments but guidelines outlining the best course of therapy are lacking.
More Related Videos
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Introduction Cardiac Emergencies
Acute Coronary Syndrome V: Nursing Management
